- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03873961
Effect of HILT vs LLLT in Treatment of Patients With Achilles Tendinitis or Plantar Fasciitis
Short and Long Term Effect of High Intensity Versus Low-Level Laser Therapy in Treatment of Patients With Achilles Tendinitis or Plantar Fasciitis: A Single Blinded Randomized Controlled Clinical Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Plantar heel pain, also known as plantar fasciitis, causes soreness or tenderness of the sole of the foot under the heel, which sometimes extends into the medial arch. Pain associated with the condition may cause substantial disability and poor health-related quality of life. Achilles tendinitis is a common etiology of posterior heel pain that results in significant pain and loss of function. Calf exercise is initial management that may be supported by laser therapy. A treatment possibility high-intensity laser therapy is little explored. High-intensity lasers can deliver more energy deeper into tissue. The hypothesis is that both lasers are effective in treatment of plantar fasciitis or Achilles tendinopathy, but high-intensity laser therapy is more effective.
The aim of this study is to evaluate and compare the changes of heel pain, functional health and well-being after high-intensity and low-level laser therapy for plantar fasciitis or Achilles tendinopathy.
The study was approved by Committee on Biomedical Research Ethics of Kaunas Region (2016-07-14 No. BE-2-32). Patients are recruited in out patient clinic of Physical Medicine and Rehabilitation Department in The Hospital of Lithuanian University of Health Sciences (LSMU) Kauno klinikos.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kaunas, Lithuania, LT 44307
- The Lithuanian University of Health Sciences, Department of Rehabilitation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- unilateral painful activity related symptoms from the Achilles region
- tenderness during palpation of Achilles insertion on calcaneus or couple centimeters above
- unilateral plantar heel pain, mainly during the first few steps upon rising in the morning
- tenderness at the insertion site of the plantar fascia o the calcaneus
Exclusion Criteria:
- bilateral heel pain
- other acute pathology (febrile fever, cold. etc.) that require treatment
- other painful conditions that require painkillers (tooth pain, back pain, etc)
- pregnancy
- history of recent trauma or foot surgery
- wounds, infections in treatment area
- impaired sensation in treatment area
- pigmentation changes on the skin in treatment area (tattoo, birthmarks)
- received oral or injected corticosteroids within the last 26 weeks
- diagnosis of systemic inflammatory arthritis (goat, rheumatoid arthritis, etc)
- diagnosis of neurological heel pain (radiculopathy)
- diagnosis of other heel pathology (calcaneal stress fracture, osteomyelitis, plantar fascia neoplasm, plantar fascia rupture, etc)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High-intensity laser therapy
The participants received stretching and exercise guidance and underwent the BTL-6000 High Intensity Laser 12 W with 10 mm pen applicator high intensity laser procedures (mode = continuous, power = 7 W, dose = 120 J/cm2, total time= 7 min.
8 sec.) 3 times per week (total of 8 procedures).
|
tissue photobiostimulation for pain reduction and healing enhancement.
Other Names:
|
Active Comparator: Low-level laser therapy
The participants received stretching and exercise guidance underwent the LAS-Expert with laser shower applicator Low-level Laser therapy procedures (785 nm wavelength, 4,0 J/cm2, 35cm2, 6:40 min) 3 times per week (total of 8 procedures).
|
tissue photobiostimulation for pain reduction and healing enhancement.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain - visual analog scale
Time Frame: Baseline
|
Visual analog scale from 0 to 100 mm ("0" = no pain, "100" = the most intense pain).
Heel pain in specific day time (at rest, first morning step, several minutes after first step, first step after prolonged sitting in the middle of the day, in the evening and at night)
|
Baseline
|
Pain - visual analog scale
Time Frame: After 3 weeks of treatment
|
Visual analog scale from 0 to 100 mm ("0" = no pain, "100" = the most intense pain).
Heel pain in specific day time (at rest, first morning step, several minutes after first step, first step after prolonged sitting in the middle of the day, in the evening and at night)
|
After 3 weeks of treatment
|
Pain - visual analog scale
Time Frame: 4 weeks follow up
|
Visual analog scale from 0 to 100 mm ("0" = no pain, "100" = the most intense pain).
Heel pain in specific day time (at rest, first morning step, several minutes after first step, first step after prolonged sitting in the middle of the day, in the evening and at night)
|
4 weeks follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain - pressure algometry
Time Frame: Baseline to 3 weeks and 4 weeks follow up
|
Pressure algometry was performed on both affected and healthy feet.
It was measured with algometer (kgf)
|
Baseline to 3 weeks and 4 weeks follow up
|
Range of motion - goniometry
Time Frame: Baseline to 3 weeks and 4 weeks follow up
|
Ankle and first toe dorsiflexion and plantarflexion was measured in both affected and healthy feet.
It was measured in standardized position with goniometer (degrees)
|
Baseline to 3 weeks and 4 weeks follow up
|
Tendon thickness measurement - ultrasound
Time Frame: Baseline to 3 weeks and 4 weeks follow up
|
Thickness of tendon was measured with ultrasound machine in longitudinal view of tendon in both affected and healthy feet (mm).
|
Baseline to 3 weeks and 4 weeks follow up
|
Functional health and well-being - SF-36v2®
Time Frame: Baseline to 3 weeks and 4 weeks follow up
|
Paper questionnaire for participants to fill in. Medical Outcomes Study Short Form 36 2 version (SF-36v2) was used. Measure is divided into 8 subscales and 2 composite domains The 8 subscales are Physical Functioning, Role Limitations due to Physical Problems, General Health Perceptions, Vitality, Social Functioning, Role Limitations due to Emotional Problems, General Mental Health and Health Transition. Respondents were asked to answer items referring to the past 4 weeks Recommended scoring system for the SF-36 is a weighted Likert system for each item Items within subscales are totaled to provide a summed score for each subscale or dimension. Each of the 8 summed scores is linearly transformed onto a scale from 0 (negative health) to 100 (positive health) to provide a score for each subscale. |
Baseline to 3 weeks and 4 weeks follow up
|
Evaluation of functional condition of patients' feet - Foot Function Index-Revised Short Form
Time Frame: Baseline to 3 weeks and 4 weeks follow up
|
Paper questionnaire for participants to fill in.
The questionnaire consists of 34 questions grouped into 5 subcategories: pain, stiffness, difficulty, activity limitation, and social issues.
The answers are represented by a 4-level Likert scale.
The numerical 5 is not a Likert scale; it is an option that the particular question is not applicable.
A higher score represents worse condition.
|
Baseline to 3 weeks and 4 weeks follow up
|
Evaluation of functional condition of patients' feet - Foot and Ankle Ability Measure
Time Frame: Baseline to 3 weeks and 4 weeks follow up
|
Paper questionnaire for participants to fill in.
Foot and Ankle Ability Measure consists of the 21-item activities of daily living and 8-item Sports subscales.
The response to each item is scored by Likert scale from 4 to 0, with 4 being "no difficulty" and 0 being "unable to do".
A higher score represents a higher level of physical function.
|
Baseline to 3 weeks and 4 weeks follow up
|
Pain - numerical pain rating scale
Time Frame: Baseline to 3, 5, 8, 10, 12, 15 and 17 days (before every laser procedure)
|
Numerical pain rating scale from 0 to 10 ("0" = no pain, "10" = the most intense pain).
Heel pain in specific day time (at rest, first morning step, several minutes after first step, first step after prolonged sitting in the middle of the day, in the evening and at night)
|
Baseline to 3, 5, 8, 10, 12, 15 and 17 days (before every laser procedure)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Raimondas Kubilius, professor, Lithuanian University of Health Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-07-14 Nr.BE-2-32
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Plantar Fascitis
-
Cairo UniversityNot yet recruiting
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...RecruitingPlantar FascitisItaly
-
Chinese University of Hong KongRecruiting
-
Istanbul Medeniyet UniversityNot yet recruiting
-
Chinese University of Hong KongRecruitingPlantar FascitisHong Kong
-
Stanford UniversityNot yet recruitingPlantar Fascitis
-
Hospital for Special Surgery, New YorkActive, not recruiting
-
Riphah International UniversityCompletedPlantar FascitisPakistan
-
Sultan Qaboos UniversityRecruitingPlantar FascitisOman
-
Mike O'Callaghan Military HospitalCompleted
Clinical Trials on High-intensity laser therapy
-
Maharishi Markendeswar University (Deemed to be...Completed
-
Ahram Canadian UniversityRecruitingMeralgia Paresthetica | Lateral Femoral Cutaneous Nerve EntrapmentEgypt
-
Ahram Canadian UniversityRecruiting
-
Quiropraxia y EquilibrioNot yet recruiting
-
Cairo UniversityNot yet recruitingPrimary Dysmenorrhea
-
Afyonkarahisar Health Sciences UniversityCompletedMusculoskeletal Diseases | Carpal Tunnel Syndrome | Median Neuropathy | Entrapment NeuropathyTurkey
-
University of PalermoCompletedAthletic Injuries | Physical TherapiesItaly
-
Université de SherbrookeCHU de Quebec-Universite Laval; Centre de recherche du Centre hospitalier universitaire... and other collaboratorsRecruiting
-
Necmettin Erbakan UniversityNot yet recruitingKnee Osteoarthritis | Laser Therapy | Muscle Strength
-
Necmettin Erbakan UniversityCompletedCarpal Tunnel SyndromeTurkey